Gosset Avalon BioVentures General Information
Avalon BioVentures is an active San Diego-based venture capital firm specializing in early-stage life sciences innovation. Through its ABV Accelerator program and hands-on approach, it forms and supports pioneering biotech startups that have advanced drug candidates across multiple indications. Its track record includes successful exits such as Synthorx (acquired by Sanofi), Calporta (acquired by Merck), Sitari Pharmaceuticals (acquired by GSK), Janux Therapeutics (IPO), PDI Therapeutics (acquired by Cullinan Oncology), Nerio Therapeutics ($1.3B acquisition by Boehringer Ingelheim). Portfolio companies have reached clinical stages rapidly due to Avalon's integrated support infrastructure
Contact Information
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Stanford University, Bregua Corporation, TigerGene, Alexandria Venture Investments, Correlation Ventures
Avalon BioVentures Funding
No funding data available